TITLE

THE EFFECTS AND MECHANISMS BETWEEN DIDS AND EDRV ON ACUTE ISCHAEMIA-REPERFUSION INJURY MYOCARDIUM

PUB. DATE
October 2010
SOURCE
Heart;Oct2010 Supplement, pA45
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "The Effects and Mechanisms Between DIDS and EDRV on Acute Ischaemia-Reperfusion Injury Myocardium" by Liu Yan-xia and colleagues is presented.
ACCESSION #
66245515

 

Related Articles

  • Myocardial protection: an expanding or contracting discipline? Wechsler, Andrew S.; Brockman, Stanley K. // Perfusion;Jul2003, Vol. 18 Issue 4, p139 

    For the past thirty years cardiac surgeons have had a unique opportunity to study the consequences of myocardial ischemia and reperfusion. With the advent of an ability to intervene in acute myocardial syndromes, cardiologists have vigorously joined that effort as have fundamental scientists....

  • Preconditioning the heart with resveratrol.  // Life Extension;Sep2002, Vol. 8 Issue 9, p76 

    Discusses the abstract of a study on the cardioprotective effect of resveratrol, a polyphenolic oxidant against ischemic-reperfusion injury.

  • REPERFUSION INJURY - CHALLENGES TO REDUCE IT. Aman, Wahaj; Hafizullah, Mohammad // Pakistan Heart Journal;2017, Vol. 50 Issue 1, p1 

    No abstract available.

  • Postconditioning markedly attenuates ventricular arrhythmias after ischemia-reperfusion. Kloner, Robert A.; Dow, Joan; Bhandari, Anil // Journal of Cardiovascular Pharmacology & Therapeutics;Mar2006, Vol. 11 Issue 1, p55 

    Background: Brief periods of reocclusion (postconditioning) during early reperfusion reduce myocardial infarct size. Whether postconditioning has an effect on lethal ventricular arrhythmias independent of infarction in an in-vivo regional ischemia model is unknown. The purpose of...

  • Effect of Levosimendan and Milrinone on Regional Myocardial Ischemia/Reperfusion-Induced Arrhythmias in Dogs. Papp, Julius Gy.; Pollesello, Piero; Varr�, Andr�s F.; V�gh, �gnes S. // Journal of Cardiovascular Pharmacology & Therapeutics;Jun2006, Vol. 11 Issue 2, p129 

    Compares the effect of levosimendan on ventricular arrhythmias in a model of acute regional myocardial ischemia and reperfusion. Association of phosphodieterase inhibitors as inodilators in heart failure with promotion of arrhythmias; Measurement of the degree if inhomogeneity of electrical...

  • Ventricular Fibrillation Induced by Ischemia-Reperfusion Is Not Prevented by the NPY Y2 Receptor Antagonist BIIE0246. Ilebekk, Arnfinn; Eriksen, Morten; Sevre, Knut; Aspelin, Trude; Bj�rkman, Jan-Arne; Lyberg, Torstein; Nordlander, Margareta // Journal of Cardiovascular Pharmacology & Therapeutics;Sep2006, Vol. 11 Issue 3, p177 

    The article presents a research which investigated the role of neuropeptide Y2 receptor antagonist BIIE0246 in preventing ventricular fibrillation induced by ischemia-reperfusion. Results of the experiment reveal that no significant difference was noted between the two groups of the experiment...

  • Reduction of Myocardial Ischemia-Reperfusion Injury with Pre- and Postconditioning: Molecular Mechanisms and Therapeutic Targets. Galagudza, Michael M.; Blokhin, Ilia O.; Shmonin, Aleksey A.; Mischenko, Kirill A. // Cardiovascular & Haematological Disorders - Drug Targets;Mar2008, Vol. 8 Issue 1, p47 

    Reduction of infarct size as well as alleviation of other ischemia- and reperfusion-associated injuries are the goals of primary importance in cardiology. One of the remedies is considered to be myocardial preconditioning (PreCon) referred usually to as an increased myocardial tolerance to...

  • Endothelin and the Ischaemic Heart. Wainwright, Cherry L.; McCabe, Christopher; Kane, Kathleen A. // Current Vascular Pharmacology;Oct2005, Vol. 3 Issue 4, p333 

    Soon after its identification as a powerful vasoconstrictor peptide, endothelin (ET-1) was implicated as a detrimental agent involved in determining the outcome of myocardial ischaemia and reperfusion. Early experimental studies demonstrated that ETA selective and mixed ETA/ETB receptor...

  • Clinical Aspects of Melatonin in the Acute Coronary Syndrome. Dominguez-Rodriguez, Alberto; Abreu-Gonzalez, Pedro; Reiter, Russel J. // Current Vascular Pharmacology;Jul2009, Vol. 7 Issue 3, p367 

    This review considers the actions of an endogenously produced molecule, melatonin, on heart diseases. Recent research has shown that inflammation plays a key role in coronary heart disease (CHD) and other manifestations of atherosclerosis. Immune cells dominate early atherosclerotic lesions,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics